Published in Medicine and Law Weekly, March 12th, 2004
CombiMatrix and NDC will share revenues on sales of new materials and tools under a joint product development and license agreement.
"The development of new nanostructured materials for commercial applications has traditionally been a cumbersome process," said Don Montgomery, president and CEO of NDC. "Electrochemistry offers the most comprehensive, reproducible...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.